Skip to content

European Medicines Agency’s (EMA) Committee For Orphan Medicinal Products (COMP) December 2012 Meeting Results

December 14, 2012

EMA’s Committee for Orphan Medicinal Products (COMP) held a meeting December 5 – 6, 2012.

The EMA COMP December 2012 Meeting Report on the review of applications for orphan designation is published December 7, 2012. At the December 2012 EMA COMP meeting, there are 13 positive opinions recommending orphan designation for the treatment of:

–          Familial adenomatous polyposis

–          Growth hormone deficiency

–          Glioma

–          Mucopolysaccharidosis type IIIB (Sanfilippo B syndrome)

–          5q Spinal Muscular Atrophy

–          Beta-thalassaemia intermedia and major

–          Ovarian cancer

–          Wilson’s disease

–          Retinitis pigmentosa

–          Follicular lymphoma

–          Achondroplasia

–          Pancreatic cancer

–          Systemic sclerosis.

The next COMP Meeting is scheduled for :

– January 8 – 9, 2013.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: